Your browser doesn't support javascript.
loading
Novel protein kinase cAMP-Activated Catalytic Subunit Alpha (PRKACA) inhibitor shows anti-tumor activity in a fibrolamellar hepatocellular carcinoma model.
Toyota, Akiko; Goto, Megumi; Miyamoto, Masaya; Nagashima, Yoko; Iwasaki, Shiho; Komatsu, Takahiro; Momose, Takayuki; Yoshida, Keisuke; Tsukada, Tomoharu; Matsufuji, Tetsuyoshi; Ohno, Ami; Suzuki, Makoto; Ubukata, Osamu; Kaneta, Yasuyuki.
Afiliación
  • Toyota A; Daiichi Sankyo Co., Ltd., Shinagawa R&D Center, 1-2-5 Hiromachi, Shinagawa-ku, Tokyo, Japan. Electronic address: toyota.akiko.gy@daiichisankyo.co.jp.
  • Goto M; Daiichi Sankyo Co., Ltd., Shinagawa R&D Center, 1-2-5 Hiromachi, Shinagawa-ku, Tokyo, Japan.
  • Miyamoto M; Daiichi Sankyo Co., Ltd., Shinagawa R&D Center, 1-2-5 Hiromachi, Shinagawa-ku, Tokyo, Japan.
  • Nagashima Y; Daiichi Sankyo Co., Ltd., Shinagawa R&D Center, 1-2-5 Hiromachi, Shinagawa-ku, Tokyo, Japan.
  • Iwasaki S; Daiichi Sankyo Co., Ltd., Shinagawa R&D Center, 1-2-5 Hiromachi, Shinagawa-ku, Tokyo, Japan.
  • Komatsu T; Daiichi Sankyo Co., Ltd., Shinagawa R&D Center, 1-2-5 Hiromachi, Shinagawa-ku, Tokyo, Japan.
  • Momose T; Daiichi Sankyo Co., Ltd., Shinagawa R&D Center, 1-2-5 Hiromachi, Shinagawa-ku, Tokyo, Japan.
  • Yoshida K; Daiichi Sankyo Co., Ltd., Shinagawa R&D Center, 1-2-5 Hiromachi, Shinagawa-ku, Tokyo, Japan.
  • Tsukada T; Daiichi Sankyo Co., Ltd., Shinagawa R&D Center, 1-2-5 Hiromachi, Shinagawa-ku, Tokyo, Japan.
  • Matsufuji T; Daiichi Sankyo Co., Ltd., Shinagawa R&D Center, 1-2-5 Hiromachi, Shinagawa-ku, Tokyo, Japan.
  • Ohno A; Daiichi Sankyo RD Novare Co., Ltd., Tokyo, Japan.
  • Suzuki M; Daiichi Sankyo RD Novare Co., Ltd., Tokyo, Japan.
  • Ubukata O; Daiichi Sankyo RD Novare Co., Ltd., Tokyo, Japan.
  • Kaneta Y; Daiichi Sankyo Co., Ltd., Shinagawa R&D Center, 1-2-5 Hiromachi, Shinagawa-ku, Tokyo, Japan.
Biochem Biophys Res Commun ; 621: 157-161, 2022 09 17.
Article en En | MEDLINE | ID: mdl-35839742

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas Límite: Adult / Humans Idioma: En Revista: Biochem Biophys Res Commun Año: 2022 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas Límite: Adult / Humans Idioma: En Revista: Biochem Biophys Res Commun Año: 2022 Tipo del documento: Article Pais de publicación: Estados Unidos